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ess: kogat@med.kurumSummary A 54-year-old female presented with an exacerbation of right middle
lobe bronchiectasis. A bronchoscopic bronchial washing and repeated trials of
sputum culture consistently recovered no other infectious agent except Exophiala
dermatitidis. Her illness was improved by administrations of intravenous miconazole
and nebulized amphotericin B when sputum cultures yielded no fungi, demonstrating
a pathogenic role of the fungi. The present case illustrates E. dermatitidis as a
pathogenic agent in non-cystic fibrosis bronchiectasis.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Exophiala dermatitidis infection is known to
manifest subcutaneous lesions, often in extremi-
ties, in immunocompetent persons, whereas more
severe infections, such as brain abscess and even
systemic infection, can occur in patients in whom
immunological defense mechanisms are compro-
mised.1,2 It is becoming clear that fungi play a
significant role as one of respiratory pathogens in
patients with cystic fibrosis.3–5 Here we describe a
patient with non-cystic fibrosis bronchiectasisElsevier Ltd. All rights reserv
31 7560;
e-u.ac.jp (T. Koga).where the fungi were the only organism recovered
from a lower airways infection. The infected
system was ameliorated by administrations of
antifungal agents, demonstrating a similar role in
bronchiectasis other than cystic fibrosis.Case report
A 54-year-old woman presented with increased
cough and sputum production. Four years ago she
was diagnosed as having right middle lobe bronch-
iectasis, and had been stable since diagnosis. Her
medical history was negative except for bronch-
iectasis and family history was unremarkable.
There were no physical findings. She was unableed.
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and sputum production. Laboratory data included
WBC; 6900/ml, CRP; 0.16mg/dl. A thoracic com-
puted tomography (CT) (Fig. 1) revealed right
middle lobe bronchiectasis with accompanying
infiltrates. Infiltrates were also noted in right S6.
Culture of expectorated sputum and a broncho-
scopic bronchial washing consistently yielded a
growth of yeast-like fungi. No other pathogens
including mycobacteria were recovered. Blood b-D-
glucan level as 41 (normal: o10) pgml, and
galactomannan (latex agglutination) was negative.
Subculture of the fungi on Sabraud agar produced
woolly to cottony colonies, colored gray to black,
on 30th day at 27 1C (Fig. 2). The isolates did not
utilize KNO3. Conidiogenous cells were intercalaryFigure 1 Thoracic CT presenting right middle lobe
bronchiectasis accompanied by infiltrates, and irregular
infiltrates in right S6.
Figure 2 Subculture of the fungi on Sabraud agar
producing woolly to cottony colonies, colored grey to
black, on 30th day at 271C.or free and flask-shaped. Annellafed zones were
elongated and relatively wide, producing ellipsoi-
dal to sub-cylindrical conidia. From these morpho-
logical and biological findings, isolates were
identified as E. dermatitidis.
Intravenous miconazole (400mg/day) and inhala-
tion amphotericin B (20mg/day) was initiated. One
month of the treatment resulted in alleviated
symptoms and an improvement in radiological
findings. Repeated sputum culture did not yield
the fungi, suggesting the fungi as the causative
agent of her illness.Discussion
The role of E. dermatitidis in the lower airways
infection has become increasingly clear, especially
in patients with cystic fibrosis. The spectrum of
complication for E. dermatitidis in cystic fibrosis
ranges from colonization4,6 to invasive infec-
tions.3,5,7 The fungi have also been reported to
cause lung disease as a part of systemic infection in
patients with compromised immunity.2 In the
woman presented here, E. dermatitidis is consid-
ered to have caused invasive lung infection
because: (1) the organism is the only pathogen
repeatedly isolated from airway samples, and (2)
clinical and radiological improvement was observed
after antifungal treatment when the organism was
eradicated.
A prospective study has demonstrated coloniza-
tion of the fungi in a significant proportion of
patients with cystic fibrosis with the application of
a specific culture method.4 Although subculture on
Sabraud agar successfully isolated the fungi in the
present patient, it is possible that E. dermatitidis
infection is missed in other clinical settings because
of fastidious nature of the fungi in growth. A case
where the fungi caused hemoptysis in a patient
with non-cystic fibrosis bronchiectasis7 and the
present case imply that there may be many other
patients with underlying bronchiectasis in whom E.
dermatitidis infection are not diagnosed.
Intravenous miconazole in combination with
amphotericin B inhalation cleared the symptoms
and fungi from the sputum in the present
case. Although there can be exceptions,7 currently
available antifungal agents, including amphotericin
B, flucytosine, itraconazole, and voriconazole,
have yielded clinical improvement in affected
individuals.2,3,5,7 Development of a guideline
for optimal diagnosis and treatment should
be established because of the potential of
substantial numbers of under diagnosed affected
individuals.
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